Cancer as a Metabolic Disease und über 1,5 Millionen weitere Bücher verfügbar für Amazon Kindle. Erfahren Sie mehr


oder
Loggen Sie sich ein, um 1-Click® einzuschalten.
oder
Mit kostenloser Probeteilnahme bei Amazon Prime. Melden Sie sich während des Bestellvorgangs an.
Jetzt eintauschen
und EUR 25,40 Gutschein erhalten
Eintausch
Alle Angebote
Möchten Sie verkaufen? Hier verkaufen
Der Artikel ist in folgender Variante leider nicht verfügbar
Keine Abbildung vorhanden für
Farbe:
Keine Abbildung vorhanden

 
Beginnen Sie mit dem Lesen von Cancer as a Metabolic Disease auf Ihrem Kindle in weniger als einer Minute.

Sie haben keinen Kindle? Hier kaufen oder eine gratis Kindle Lese-App herunterladen.

Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer [Englisch] [Gebundene Ausgabe]

Thomas Seyfried
5.0 von 5 Sternen  Alle Rezensionen anzeigen (2 Kundenrezensionen)
Preis: EUR 109,77 kostenlose Lieferung. Siehe Details.
  Alle Preisangaben inkl. MwSt.
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Nur noch 7 auf Lager (mehr ist unterwegs).
Verkauf und Versand durch Amazon. Geschenkverpackung verfügbar.
Lieferung bis Samstag, 4. Oktober: Wählen Sie an der Kasse Morning-Express. Siehe Details.

Weitere Ausgaben

Amazon-Preis Neu ab Gebraucht ab
Kindle Edition EUR 76,84  
Gebundene Ausgabe EUR 109,77  

Kurzbeschreibung

27. Juli 2012
The book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism. However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited. This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requring metabolic solutions for its management and prevention. Support for this position is derived from critical assessment of current cancer theories. Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate.

Wird oft zusammen gekauft

Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer + Krebszellen lieben Zucker - Patienten brauchen Fett
Preis für beide: EUR 134,76

Die ausgewählten Artikel zusammen kaufen


Produktinformation

  • Gebundene Ausgabe: 438 Seiten
  • Verlag: John Wiley & Sons; Auflage: 1. Auflage (27. Juli 2012)
  • Sprache: Englisch
  • ISBN-10: 0470584920
  • ISBN-13: 978-0470584927
  • Größe und/oder Gewicht: 24,1 x 15,5 x 2,8 cm
  • Durchschnittliche Kundenbewertung: 5.0 von 5 Sternen  Alle Rezensionen anzeigen (2 Kundenrezensionen)
  • Amazon Bestseller-Rang: Nr. 119.895 in Fremdsprachige Bücher (Siehe Top 100 in Fremdsprachige Bücher)
  • Komplettes Inhaltsverzeichnis ansehen

Mehr über den Autor

Entdecken Sie Bücher, lesen Sie über Autoren und mehr

Produktbeschreibungen

Pressestimmen

"This book offers a refreshing perspective for anyone wanting to get a comprehensive background on the newer emerging interest in targeting cancer metabolism for therapy." (Doody's, 11 January 2013)
 
"For the first time, an entire issue is being devoted to a review article based on a recent medical book. This is a departure from our usual format, but I think you will agree that this topic warrants the detailed treatment we have given it . . .This book should be required reading for all scientifically literate people who are involved in the cancer problem." (Advances in Cancer Treatment, 1 October 2012)

Buchrückseite

A groundbreaking new approach to understanding, preventing, and treating cancer
 
Supported by evidence from more than 1,000 scientific and clinical studies, this groundbreaking book demonstrates that cancer is a metabolic disease and, more importantly, that it can be more effectively managed and prevented when it is recognized as such. Moreover, the book provides detailed evidence that the traditional view of cancer as a genetic disease has been largely responsible for the failure to develop effective therapies and preventive strategies.
 
Cancer as a Metabolic Disease reevaluates the origins of cancer based on the latest research findings as well as several decades of studies exploring the defects in tumor cell energy metabolism. Author Thomas Seyfried is a biochemical geneticist who has been investigating the lipid biochemistry of cancer for thirty years. In this book, he carefully establishes why approaching cancer as a metabolic disease leads to better understanding and management of all aspects of the disease, including inflammation, vascularization, cell death, drug resistance, and genomic instability. In addition, the book explores:
* Origin of metastasis
* New treatment strategies that target tumor cell energy metabolism, including the ketogenic diet
* More effective prevention strategies in light of the metabolic origin of cancer
* Case studies and perspectives from the point of view of physicians, patients, and caregivers
 
Throughout the book, tables, figures, and graphs summarize key information and clarify complex concepts. In addition, the renowned cancer biochemist Peter Pedersen from Johns Hopkins Medical School also provides a historical perspective on the importance of the information presented in his foreward to the book.
 
Cancer as a Metabolic Disease is essential reading for all cancer researchers and clinicians as well as public health professionals. By treating cancer as a metabolic disease, the book sets readers on a new, more promising path to understanding the origins of cancer and developing new, more effective strategies to treat and prevent it.

In diesem Buch (Mehr dazu)
Ausgewählte Seiten ansehen
Buchdeckel | Copyright | Inhaltsverzeichnis | Auszug | Stichwortverzeichnis | Rückseite
Hier reinlesen und suchen:

Kundenrezensionen

4 Sterne
0
3 Sterne
0
2 Sterne
0
1 Sterne
0
5.0 von 5 Sternen
5.0 von 5 Sternen
Die hilfreichsten Kundenrezensionen
4 von 4 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen Wissenschaftlich ausgezeichnete Arbeit 14. April 2013
Format:Gebundene Ausgabe|Verifizierter Kauf
DIe Bewertung zielt genau auf das, was Thomas Seyfried anzeigt, nämlich wie Krebs und Tumore "gefüttert" werden und wie man die Standardbehandlung gibt, um wieder daraus zu kommen. Nicht mehr und nicht weniger....
Es ist wissenschaftlich unterlegt, jedoch kein Buch für Krebskranke als "Selbsthilfebuch" weil es zu schwierig ist. Jedoch gibt es die richtigen Lösungsansätze, um dann endlich auch die richtigen Lösungen und Begleitung zu bekommen....
Mir hat es bewiesen und angezeigt, dass meine Vermutungen mehr als bestätigt wurden und habe hiermit einen wissenschaftlich unwiderlegbaren Beweis gegeben, was Krebs eigentlich ist.
Zu empfehlen an jeden, der Krebs hat und sicherlich an alle Onkologen, Heilpraktiker, gesundheitbewuste Menschen und Ärzte, die einen hohen Lernindex haben, um auch diese Konzepte in die Behandlungen mit einfliessen zu lassen.
Mein Tipp ist es, um einmal kurz das Video an zu schauen, weil das eine Kurzfassung ist und den nötigen Überblick gibt. Sicherlich nicht blindlings jetzt den Ernährungsbüchern folgen, weil hier wichtige Elemente fehlen, die Seyfried deutlich anzeigt...
War diese Rezension für Sie hilfreich?
5.0 von 5 Sternen fantastic new look at cancer 23. Juli 2013
Format:Gebundene Ausgabe|Verifizierter Kauf
this book redefines cancer as a metabolic rather than a genetic disease, and shows how it is an illness that can be managed with diet. Seyfried is a top-notch scientist who offers an alternative for cancer care to the traditional chemo- and radiation therapy. The central idea is that cancer cells require glucose for their metabolic energy needs, but our bodies developed evolutionarily to be able to metabolize fats as well as glucose. By switching our metabolism to a ketosis state we can literally starve the cancer right out of our body.
War diese Rezension für Sie hilfreich?
Die hilfreichsten Kundenrezensionen auf Amazon.com (beta)
Amazon.com: 4.4 von 5 Sternen  45 Rezensionen
146 von 147 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen Compelling evidence to support cancer as a metabolic disease 2. Juli 2012
Von Dominic D'Agostino - Veröffentlicht auf Amazon.com
Format:Gebundene Ausgabe|Verifizierter Kauf
Dr. Seyfried provides compelling evidence that cancer is a metabolic disease (NOT a genetic disease), and this has major implications for the treatment and prevention of cancer.

According to Otto Warburg's theory of cancer, mitochondrial dysfunction is the origin of cancer. Dr. Seyfried has amassed extensive evidence to support Warburg's theory and advances the idea that cancer arises from defects in energy metabolism (mitochondrial dysfunction), and that this metabolic dysfunction triggers genomic instability, activates oncogenes and inactivating tumor suppressor genes. The author does an incredible job at convincing the reader that healthy mitochondria are the ultimate tumor suppressor.

It's clear that the strategy to treat cancer as a genetic disease is not working following metastasis of solid primary tumors, but this fuels the pharmaceutical industry. Enormous amounts of money are spent on large cancer genome projects, but this has not advanced our understanding or treatment of cancer as expected. The cancer genome project has actually created more confusion amongst cancer researchers, and this is very clear if one reads the literature. On the other hand, when cancer is viewed as a metabolic disease the strategies to treat and prevent cancer become incredibly simplistic and economical. For example, animals studies, case reports and anecdotal evidence demonstrate that metabolic therapies that lower blood glucose and elevate ketones will quickly reduce tumor growth, extend lifespan and in some cases cause complete remission. This strategy is effective because cancer cells are fueled by glucose and lack the ability to derive energy from ketones due to mitochondrial defects. Metabolic therapies exploit the mitochondrial defects associated with cancer by targeting glucose metabolism, reducing insulin and elevating ketones. These therapies are simple and include "therapeutic fasting", calorie restricted ketogenic diets and relatively cheap and safe drugs that target glycolysis, insulin and other cancer-specific metabolic pathways. The information in this book is valuable to patients and supported by extensive references. This book is technical (in parts), but the author has the ability to describe complicated processes with elegant simplicity.

I read this book immediately after reading "The Secret History of the War on Cancer" and "The Emperor of All Maladies". These are excellent books, but I found Dr. Seyfried's book to be more informative and empowering because it gives the reader clear evidence for the cause of cancer and highly effective strategies to prevent and treat the disease.

I would recommend this book to all cancer researchers, oncologists and layman interested in understanding the origin, management and treatment of cancer as a metabolic disease. This book will also be an extremely valuable resource for patients diagnosed with cancer.
Dominic D'Agostino, PhD, University of South Florida
97 von 99 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen The Most Important Book about Cancer Cell Metabolism 1. September 2012
Von Stephen Strum - Veröffentlicht auf Amazon.com
Format:Kindle Edition|Verifizierter Kauf
I am a board-certified medical oncologist with 30 years experience in caring for cancer patients and another 20 years of research in cancer medicine dating back to 1963. Seyfried's "Cancer as a Metabolic Disease" is the most significant book I have read in my 50 years in this field. It should be required reading of all cancer specialists, physicians in general, scientific researchers in the field of cancer and for medical students. I cannot overstate what a valuable contribution Thomas Seyfried has made in writing this masterpiece.
Stephen B. Strum, MD, FACP
Medical Oncologist, Member of ASCO (American Society of Clinical Oncology) since 1975
84 von 87 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen a new look at caloric restriction and cancer 26. Juni 2012
Von GWY - Veröffentlicht auf Amazon.com
Format:Gebundene Ausgabe
It has been known for a long time that caloric restriction led to longevity but also that it stopped cancer growth, some completely and many partial suppression with later recurrences.

Dr. Seyfried spent his whole career looking at an old concept defining cancer as a metabolic abnormality (Warburg). The fact that our PET scans show high glucose uptake in almost all types of cancer proves that cancers have a unique metabolic abnormality unlike normal differentiated cells. Simply put cancer cells require large amounts of glucose, or sugar to survival and multiply.

The cancer cells have an inefficient metabolism utilizing fermentation or glycolysis instead of using mitochondria for a more efficient way of make ATP energy via oxidative phosphorylation.

Why our own medical profession has not looked into this feature of cancer for therapeutic strategies is also odd.
It is well know that Caloric Restriction stops cancer growth and many nutritional support such as macrobiotics and Hippocrates raw foods all have the common denominator of -- low calories with dense nutrition.

I suspect in the next 10 years there will be more discussions and research on use caloric restrictions, on use of alternative body fuel or energy source such as ketones, and glucose analogues, and ways to disrupt glycolysis and abnormal mitochondrial functions by using metabolic approaches to treat cancers.

I recommend this book to layman and professionals who are interested in the biology of cancers. top rating
74 von 80 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen Iconoclastic approach to cancer 23. Juli 2012
Von Joseph Maroon, MD - Veröffentlicht auf Amazon.com
Format:Gebundene Ausgabe|Verifizierter Kauf
Dr. Seyfried has distilled a life time of basic science investigation into a brilliant summary of the causes of cancer. Although heavily scientific it reads like a mystery novel.
He directly challenges the prevalent "gene theory" of cancer that forms the basis of virtually all investigative efforts into cancer. He then details the origin, scientific basis and practicality of the metabolic cause of cancer.
Most importantly, he proposes a paradigm shift in how we should at least consider treating malignancies and in particular, brain cancer.
Based on evolutionary biology this book makes sense! It should be read by every scientist involved with the biology and treatment of cancer and by laymen with a scientific background. It is one of the most important books I have read as a neurosurgeon dealing with brain tumor patients in over 25 years.
40 von 42 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen Cancer *Is* a Metabolic Disease 4. März 2013
Von Greg Nigh - Veröffentlicht auf Amazon.com
Format:Gebundene Ausgabe|Verifizierter Kauf
It is rare these days to read a new idea within the field of cancer, its causes and its treatment. There is no absence of old ideas, to be sure, but they are remarkably underwhelming in their explanatory power, and even less impressive in their ability to generate new and useful therapies.

Seyfried enters this field not only with some new ideas about causes, but some most excellent new ideas about therapeutics. And most surprising, he does it all in the context of a writing style that is both readable and even enjoyable. His recurring interjections with "Hello! Oncologists, are you listening?" seem, at the same time, out of place in an academic text and a welcome and needed shout at the conventional oncology world that has been oblivious to the evidence Seyfried amasses.

Seyfried's thesis might be summarized as, "It's the mitochondria, Stupid!" While the conventional oncology world has focused on a small percentage of characteristics that are unique to each type of cancer, Seyfried is calling attention to the set of changes that are common to all cancers, regardless of type. And central to those commonalities are specific alterations in mitochondrial function and the metabolic and genetic changes that flow from them.

Most importantly, Seyfried shows the obvious therapeutic interventions that are indicated by his thesis. The unfortunate point is that the therapies he is advocating are not likely to be embraced in the oncology world generally. For example, a very specific calorie-restricted diet for cancer patients is critical, and flies in the face of the common horrendous nutritional advice given to cancer patients, which is to eat lots of calories - in any form - just to maintain weight. Seyfried's nutritional approach to cancer control requires a great deal of patient *and physician* education about nutrition.

This is just one aspect of treatment addressed in the book. Overall, I found it to be well-written, well-substantiated, and clinically relevant. In the oncology world, that is an exceedingly rare Trifecta. I recommend this text for every health care practitioner involved in the treatment of cancer, and for cancer patients looking for a science-based understanding of their disease. Patients will end up with a list of critical questions to ask their oncologist, questions that will likely make those oncologists very uncomfortable.
Waren diese Rezensionen hilfreich?   Wir wollen von Ihnen hören.
Kundenrezensionen suchen
Nur in den Rezensionen zu diesem Produkt suchen

Kunden diskutieren

Das Forum zu diesem Produkt
Diskussion Antworten Jüngster Beitrag
Noch keine Diskussionen

Fragen stellen, Meinungen austauschen, Einblicke gewinnen
Neue Diskussion starten
Thema:
Erster Beitrag:
Eingabe des Log-ins
 

Kundendiskussionen durchsuchen
Alle Amazon-Diskussionen durchsuchen
   


Ähnliche Artikel finden


Ihr Kommentar